Design and Synthesis of Cytotoxic Compounds by Targeting Cancer Metabolism
Loading...
Other Version
External File or Record
Can’t use the file because of accessibility barriers? Contact us
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Permanent Link
Abstract
Apart from the well-known properties of malignant cells such as abnormal proliferation, deregulation of apoptosis, and cell cycle, it has now been well established that cancer cells use an altered metabolism compared to normal cells. In fact, cancer cells undergo metabolic re-programming to meet increased energetic and anabolic needs, including those for ATP, reduced coenzymes (e.g., NADPH), lipids, proteins, and nucleotides. Therefore, therapies targeting the metabolic differences between cancers and normal cells have long been a principal strategy for developing novel anticancer drugs for cancer treatment. In this presentation, the synthesis and anticancer properties of three series of novel anticancer compounds will be discussed, which have been designed based on the metabolic differences between cancers and normal cells.
Series and Number:
EducationalLevel:
Is Based On:
Target Name:
Teaches:
Table of Contents
Description
Keywords
Cancer metabolism, Cytotoxic compounds, Anticancer drug development, Medicinal chemistry, Chemical synthesis, hiol alkylation, Apoptosis, Tumor selectivity
Citation
Journal
DOI
Rights
This work may be protected by copyright unless otherwise stated.
Type
Presentation